Vathiotis, Ioannis A. http://orcid.org/0000-0002-1772-5986
Yang, Zhi http://orcid.org/0000-0002-6577-8943
Reeves, Jason
Toki, Maria http://orcid.org/0000-0002-7074-7148
Aung, Thazin Nwe
Wong, Pok Fai
Kluger, Harriet
Syrigos, Konstantinos N.
Warren, Sarah
Rimm, David L. http://orcid.org/0000-0001-5820-4397
Funding for this research was provided by:
Navigate Biopharma
Article History
Received: 31 August 2020
Accepted: 16 April 2021
First Online: 28 May 2021
Competing interests
: Z.Y., J.R., S.W. are employees of Nanostring. D.L.R. reports grants from Eli Lilly Co, during the conduct of the study; personal fees from Amgen, grants and personal fees from Astra Zeneca, personal fees from Biocept, personal fees from BMS, personal fees from Cell Signaling Technology, grants and personal fees from Cepheid, personal fees from Daiichi Sankyo, personal fees from GSK, grants and personal fees from Konica Minolta, personal fees from Merck, personal fees and non-financial support from Nanostring, grants and personal fees from NextCure, personal fees from Odonate, personal fees from PAIGE.AI, personal fees from Roche, personal fees from Sanofi, personal fees from Ventana, grants and personal fees from Ultivue, outside the submitted work.